Clinical Trial Update: Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved) [Phase 3]

View source ↗

Summary

Phase 3 CHARM Preserved trial evaluating candesartan cilexetil in heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• candesartan cilexetil (candesartan cilexetil)

Snippet

Sponsor: AstraZeneca | Conditions: Congestive Heart Failure | Phase 3 | Status: COMPLETED